Evaluation of national cannabis care needs for therapeutic purposes

03/09/2021 6 min read

Canadian caregivers have evaluated how much they are informed about cannabis.

A comprehensive study conducted in Canada between 2013 and 2014 has revealed significant deficiencies in the knowledge of nurse practitioners (NPs) regarding cannabis for therapeutic purposes. This national research is especially relevant in the current context, where interest in cannabis collector seeds and the study of their genetic profiles has experienced significant growth.

Regulatory framework for therapeutic cannabis in Canada

The Canadian system for Access to Cannabis for Medical Purposes (ACMPR) grants authorized healthcare professionals the ability to prescribe therapeutic cannabis to patients who meet certain medical criteria. This expansion of professional competencies has generated the need to develop specialized training programs that address both the pharmacological and clinical aspects of medicinal cannabis.

Nurse practitioners are in a unique position within the healthcare system, as they maintain direct and continuous contact with patients. Their role is crucial to ensure quality care in the field of therapeutic cannabis, making it essential that they have up-to-date knowledge of cannabinoid profiles, terpene profiles, and genetic characteristics of the different available varieties.

Methodology and scope of the research

This quantitative exploratory study was designed to assess the educational gaps among Canadian nurse practitioners regarding therapeutic cannabis. The research lasted ten months, from August 2013 to June 2014, covering the entire Canadian national territory.

The researchers used email lists provided by various Canadian nursing organizations to contact professionals. The questionnaire used was adapted from previous studies that had assessed the educational needs of Canadian physicians in the same field, allowing comparisons to be made between different healthcare groups.

The survey assessed multiple dimensions:

Level of knowledge about therapeutic cannabis
Prior practical experience
Identified barriers in clinical practice
Attitudes toward medicinal cannabis
Preferences regarding future educational formats

Main findings of the study

The results obtained from a sample of 182 healthcare professionals distributed across Canada revealed important areas for improvement. The most significant deficiencies were identified in aspects related to dosing and the development of effective therapeutic plans for patients using cannabis for medicinal purposes.

It is particularly striking that 76.3% of respondents considered training in therapeutic cannabis as "very necessary" or "extremely necessary." This data reflects the existing professional awareness of educational gaps and the willingness to improve competencies in this field.

Regarding attitudes toward prescribing medicinal cannabis through the ACMPR system, more than half of the professionals (57%) stated they agreed with this practice. However, this percentage increased to 64% when the possibility of receiving adequate training beforehand was raised, underscoring the importance of specialized educational programs.

Implications for the collector seed sector

These findings have direct implications for the world of cannabis collector seeds. The demand for specialized knowledge from healthcare professionals creates opportunities for collectors and cannabis genetics experts to contribute to the development of specialized educational resources.

The study of terpene profiles, cannabinoid composition, and aromatic characteristics of different genetics takes on special relevance in this context. Healthcare professionals need to understand how different varieties can present distinct therapeutic profiles, information that has traditionally been the domain of collectors and cannabis genetics specialists.

Identified educational needs

The research identified several critical areas where healthcare professionals require specialized training. These include knowledge of different administration methods, understanding of pharmacological interactions, and the ability to develop personalized treatment plans.

The researchers emphasized the need for regulatory organizations to work in collaboration with academic institutions and government agencies to develop specific educational and clinical competencies for therapeutic cannabis.

Future perspectives

The results of this pioneering study have established the foundations for the development of specialized training programs that address the identified gaps. The research underscores the importance of creating educational resources that not only cover basic pharmacological aspects but also include detailed information about the genetic characteristics and chemical profiles of different cannabis varieties.

For the seed collector community, these findings represent a unique opportunity to contribute to scientific knowledge through the study and documentation of the characteristics of different genetics. The exchange of knowledge between specialized collectors and healthcare professionals can result in better outcomes for patients and greater scientific recognition of the therapeutic value of cannabis.

Reference source: "A National Needs Assessment of Canadian Nurse Practitioners Regarding Cannabis for Therapeutic Purposes."